Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
9-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #677
advertisement
Clinical and Experimental Ophthalmology
5
Showing records 1 to 5 |
Display all abstracts in
Clinical and Experimental Ophthalmology
20007
Risk factors for primary open-angle glaucoma in a Burmese population: the Meiktila Eye Study
Casson RJ; Gupta A; Newland HS; McGovern S; Muecke J; Selva D; Aung T
Clinical and Experimental Ophthalmology
2007; 35: 739-744
19910
Co-prescribing of topical and systemic β-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice
Goldberg I; Adena MA
Clinical and Experimental Ophthalmology
2007; 35: 700-705
20077
Effects of latanoprost, timolol and GLC756, a novel dopamine D
2
agonist and D
1
antagonist on LTC
4
release after rat mast cell activation
Laengle UW; Markstein R; Pralet D; Seewald W; Roman D
Clinical and Experimental Ophthalmology
2007; 35: 645-650
20079
Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data
Rait JL; Adena MA
Clinical and Experimental Ophthalmology
2007; 35: 602-611
20078
Current licensing authority standards for peripheral visual field and safe on-road senior aged automobile driving performance
Silveira S; Jolly N; Heard R; Clunas NJ; Kay L
Clinical and Experimental Ophthalmology
2007; 35: 612-620
Issue
9-4
Table of Contents
Editor's Selection
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement